Long-term subcutaneous administration of apomorphine or insulin for Parkinson's disease or diabetes and skin event rates

被引：0
|
作者：
Wells, K. [5 ]
Zhou, S. [1 ]
Engelhard, J. [6 ]
Oleske, D. [2 ]
Werner, B. [3 ]
Facheris, M. [2 ]
Zamudio, J. [4 ]
机构：
[1] IQVIA, Fairfax, VA USA
[2] Global Epidemiol, N Chicago, IL USA
[3] Team Gesundheit GmbH, Essen, Germany
[4] AbbVie, Mettawa, IL USA
[5] MedSci, Durham, NC USA
[6] IQVIA, Frankfurt, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-121
引用
收藏
页码：515 / 515
页数：1
相关论文
共 50 条
  • [21] Intermittent subcutaneous apomorphine therapy in Parkinson's disease
    Factor, SA
    NEUROLOGY, 2004, 62 (06) : S12 - S17
  • [22] Intermittent Subcutaneous Injections of Apomorphine in Parkinson's Disease
    Ceylan, Mustafa
    Gultekin, Murat
    Celik, Nazli Durmaz
    Samanci, Bedia
    Cakmakli, Gul Yalcin
    Yilmaz, Rezzak
    EURASIAN JOURNAL OF MEDICINE, 2022, 54 : S71 - S76
  • [23] APOMORPHINE SUBLINGUAL FILM FOR "OFF" EPISODES IN PARKINSON'S DISEASE: LONG-TERM SAFETY AND EFFICACY
    Factor, S.
    Ondo, W. G.
    Isaacson, S.
    Zhang, I.
    Navia, B.
    Pappert, E.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 41 - 42
  • [24] Long-Term Safety and Efficacy of Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's Disease
    Factor, S.
    Ondo, W.
    Isaacson, S.
    Zhang, I.
    Pappert, E.
    Navia, B.
    MOVEMENT DISORDERS, 2021, 36 : S171 - S171
  • [25] A 10-year retrospective audit of long-term apomorphine use in Parkinson's disease
    Tyne, HL
    Parsons, J
    Sinnott, A
    Fox, S
    Steiger, MJ
    Fletcher, NA
    MOVEMENT DISORDERS, 2002, 17 : S75 - S76
  • [26] Long-term clinical and cognitive follow up in patients with advanced Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation
    Isaias, I. U.
    Rodolfi, G.
    Landi, A.
    Natuzzi, F.
    Pezzoli, G.
    Antonini, A.
    JOURNAL OF NEUROLOGY, 2009, 256 : S16 - S17
  • [27] Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease: A Single-Center, Long-Term Follow-Up Study of the Causes for Discontinuation
    Henriksen, Tove
    Staines, Harry
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [28] Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease
    Colzi, A
    Turner, K
    Lees, AJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (05): : 573 - 576
  • [29] THE FEASIBILITY OF LONG-TERM TREATMENT OF DIABETES WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    BELL, DSH
    CUTTER, G
    CLEMENTS, RS
    DIABETES NUTRITION & METABOLISM, 1993, 6 (01) : 57 - 60
  • [30] Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease
    Hellmann, Mark A.
    Sabach, Tilda
    Melamed, Eldad
    Djaldetti, Ruth
    BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (04) : 250 - 252
12345